When Sample Type Matters: The Utilization of Fibroblast Testing in Hereditary Cancer
Watch Video
Empower
Resources related to Empower hereditary cancer testing
-
-
Cell Culturing for Skin Fibroblast Testing Requisition Form
Read More
-
Fibroblast Ordering Guide
Read More
-
Fibroblast Brochure
Read More
-
Signatera Altera & Empower Patient Card
Read More
-
Understanding Your Risk: The Role of Hereditary Cancer Testing in Prevention
Read Article
-
Looking Back at 2025: How Natera Supported Cancer Survivors
Read Article
-
Empower RNA analysis white paper
Read More
-
Refining the interpretation of variants of uncertain significance in hereditary cancer screening through integrated RNA sequencing
Read More
-
Poor compliance with germline testing recommendations in colorectal cancer patients undergoing molecular residual disease testing
Read More
-
Capture More Patients & Families Who Can Benefit from Hereditary Cancer Testing
Utilizing the Natera Hereditary Cancer Alert Program and Oncologist Initiated Testing
Watch Video
-
Empower Gene Table - 81 Gene Panel Additional Cancer Risks
Read More
-
Empower Gene Table - 85 Gene Table by Panel
Read More
-
Empower Gene Table - 40 Gene Multi-Cancer Panel
Read More
-
Genetic Counseling in Cancer Care
ctDNA for Molecular Residual Disease (MRD) Detection & New Tools for Improved Hereditary Cancer Testing Uptake
Watch Video
-
Empower Family Health Questionnaire
Read More
-
Performance of the Empower Comprehensive Hereditary Cancer Test
Read More
-
Leveraging Signatera Residual Disease Test (MRD) to Support More Patients Who Can Benefit from Hereditary Cancer Testing
New Hereditary Cancer Alert Program (HCAP) Pilot Increase Patients Tested by 200%
Watch Video
-
Hereditary cancer testing in a diverse sample across three breast imaging centers
Westbrook, L. et al. Breast Cancer Research and Treatment 2023
Read More
-
Maternal health matters: findings from prenatal genetic screening with implications beyond pregnancy care
Watch Video
-
Loading More...
